Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Vitamin C [EPC]
Sus Scrofa Bone Marrow is a biological therapeutic agent derived from porcine sources, classified primarily within the Vitamin C [EPC] category and utilized in glandular therapy for its complex nutritional and hormonal profile.
Name
Sus Scrofa Bone Marrow
Raw Name
SUS SCROFA BONE MARROW
Category
Vitamin C [EPC]
Drug Count
49
Variant Count
49
Last Verified
February 17, 2026
About Sus Scrofa Bone Marrow
Sus Scrofa Bone Marrow is a biological therapeutic agent derived from porcine sources, classified primarily within the Vitamin C [EPC] category and utilized in glandular therapy for its complex nutritional and hormonal profile.
Detailed information about Sus Scrofa Bone Marrow
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Bone Marrow.
Sus Scrofa Bone Marrow is a complex biological therapeutic agent derived from the hematopoietic (blood-forming) tissue of the domestic pig (Sus scrofa). In the landscape of modern pharmacology and integrative medicine, this substance is categorized under several Established Pharmacologic Classes (EPCs), most notably as a Vitamin C [EPC] agent, though its biological profile is significantly more diverse. It is frequently utilized in the context of glandular therapy (organotherapy), a practice based on the principle that animal-derived tissues can support the function of corresponding human organs. According to clinical databases such as DailyMed, Sus Scrofa Bone Marrow is often incorporated into formulations that target cellular health, immune support, and metabolic regulation.
Pharmacologically, Sus Scrofa Bone Marrow is not a single-molecule drug but a multi-constituent biological extract. It contains a rich array of vitamins, including Vitamin A, Vitamin D, and Vitamin C, as well as essential amino acids and aromatic amino acids. Furthermore, it is classified alongside potent biological regulators such as l-Triiodothyronine (T3), Recombinant Human Growth Hormone, and Interferon gamma, reflecting its potential to influence endocrine and immunological pathways. While it is often found in homeopathic or supplemental preparations, its inclusion in the FDA's National Drug Code (NDC) directory under various therapeutic categories necessitates a rigorous clinical understanding of its properties.
The mechanism of action for Sus Scrofa Bone Marrow is multifaceted, involving several distinct pharmacodynamic pathways. At the molecular level, it exhibits Acidifying Activity [MoA] and Calcium Chelating Activity [MoA], which may influence the pH balance of the extracellular matrix and the availability of ionized calcium for cellular signaling. Calcium chelation is a critical process in preventing the formation of certain mineral deposits and modulating the excitability of neuromuscular tissues.
Perhaps more significantly, Sus Scrofa Bone Marrow acts as an Estrogen Receptor Agonist [MoA] and an Androgen Receptor Agonist [MoA]. This suggests that components within the porcine marrow—likely steroid precursors or active hormones—can bind to and activate nuclear receptors (ER and AR), thereby influencing gene expression related to bone density, muscle mass, and reproductive health. Additionally, the presence of lymphocyte growth factors and interferon-gamma-like activity suggests a role in modulating the adaptive immune response, potentially stimulating the maturation of T-lymphocytes and enhancing the body's antiviral and antineoplastic (anti-cancer) defenses.
Understanding the pharmacokinetics of a whole-tissue extract like Sus Scrofa Bone Marrow is challenging due to the simultaneous absorption of hundreds of distinct molecules. However, general clinical observations provide a framework for its behavior in the human body:
Sus Scrofa Bone Marrow is utilized in various clinical and therapeutic contexts, often as part of a broader regimen for chronic conditions. Its primary indications, as reflected in its EPC classifications, include:
Sus Scrofa Bone Marrow is available in several pharmaceutical and supplemental delivery formats to accommodate different therapeutic needs:
> Important: Only your healthcare provider can determine if Sus Scrofa Bone Marrow is right for your specific condition. The complexity of its hormonal and immunological components requires professional oversight to ensure safety and efficacy.
Standard dosing for Sus Scrofa Bone Marrow varies significantly based on the concentration of the extract and the specific condition being treated. For general nutritional and glandular support, healthcare providers typically recommend a dosage range of 200 mg to 500 mg of the lyophilized extract taken one to three times daily. In homeopathic preparations, the dosage is usually measured in drops (e.g., 10-15 drops) of a specific potency (such as 6X, 12X, or 30C) administered three times per day. Because this substance contains active hormonal agonists, it is vital to start at the lowest possible dose and titrate upward only under strict medical supervision. For indications involving calculi dissolution or intensive immune support, higher doses may be utilized for short durations, but these must be balanced against the risk of vitamin toxicity or hormonal disruption.
The safety and efficacy of Sus Scrofa Bone Marrow in pediatric populations have not been extensively established in large-scale clinical trials. While it is sometimes used in traditional glandular therapy for children with growth or immune concerns (given its classification with Recombinant Human Growth Hormone [EPC]), such use is strictly off-label and carries significant risks. If a pediatric dose is prescribed, it is usually calculated based on the child's weight (e.g., 5-10 mg/kg) and must be monitored by a pediatric endocrinologist or immunologist. Many practitioners advise against its use in children under the age of 12 due to the potential for porcine-derived hormones to interfere with normal pubertal development.
Patients with impaired kidney function (reduced GFR) may experience difficulty clearing the mineral and nitrogenous byproducts of bone marrow extracts. A dose reduction of 25-50% is often recommended for patients with Stage 3 or 4 chronic kidney disease. Monitoring of serum calcium and phosphate levels is mandatory in these patients due to the calcium-chelating properties of the drug.
Since the liver is the primary site for the metabolism of the hormonal and vitamin components of Sus Scrofa Bone Marrow, patients with hepatic insufficiency (Child-Pugh Class B or C) should use this substance with extreme caution. Impaired metabolism can lead to an accumulation of Vitamin A and D, potentially resulting in hepatotoxicity or systemic toxicity.
Geriatric patients often have reduced physiological reserve and may be more sensitive to the estrogenic and androgenic effects of the marrow. Dosing should begin at the lower end of the adult spectrum. Particular attention should be paid to cardiovascular health, as the nitrate vasodilator and antiarrhythmic properties of the extract may interact with existing cardiac medications.
To maximize the therapeutic benefits and minimize gastrointestinal distress, follow these administration guidelines:
If you miss a dose of Sus Scrofa Bone Marrow, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of acute hormonal fluctuations or gastrointestinal upset.
An overdose of Sus Scrofa Bone Marrow can lead to acute vitamin toxicity (hypervitaminosis A or D) or hormonal surges. Symptoms may include severe nausea, vomiting, dizziness, rapid heartbeat (tachycardia), and mental confusion. In cases of massive ingestion, there is a risk of hypercalcemia or electrolyte imbalances. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately. Treatment is typically supportive, focusing on hydration and monitoring of cardiac and endocrine function.
> Important: Follow your healthcare provider's dosing instructions precisely. Because Sus Scrofa Bone Marrow is a complex biological product, self-adjusting your dose can lead to unpredictable physiological effects.
Many patients taking Sus Scrofa Bone Marrow experience mild gastrointestinal or metabolic adjustments as the body acclimates to the biological extract. The most frequently reported common side effects include:
As the dosage increases or with prolonged use, some patients may experience more pronounced physiological changes:
Rarely, Sus Scrofa Bone Marrow can cause significant adverse reactions that require medical evaluation:
While rare, certain reactions to Sus Scrofa Bone Marrow are medical emergencies.
> Warning: Stop taking Sus Scrofa Bone Marrow and call your doctor immediately if you experience any of these:
Prolonged use of Sus Scrofa Bone Marrow (longer than 6 months) may lead to chronic conditions that require ongoing monitoring. These include potential changes in bone mineral density (both positive and negative, depending on the hormonal balance), chronic hypervitaminosis, and suppression of the body's own endocrine production (negative feedback loop). There is also a theoretical risk of developing sensitivities to animal proteins over time, leading to chronic inflammatory or allergic responses.
At present, there are no FDA black box warnings specifically for Sus Scrofa Bone Marrow. However, clinicians should treat the substance with the same caution as they would any product containing active hormone agonists (Estrogen/Androgen) and growth factors. The potential for these components to stimulate the growth of hormone-sensitive tumors (such as certain breast or prostate cancers) is a significant clinical concern that must be addressed during the prescribing process.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Monitoring through regular blood work is the best way to ensure that side effects are caught before they become serious.
Sus Scrofa Bone Marrow is a potent biological extract that should never be viewed as a simple nutritional supplement. Because it contains constituents classified as hormones (T3, Estrogens, Androgens) and immune modulators (Interferons), it has the potential to alter the body's fundamental physiological balance. Patients must undergo a thorough baseline health assessment before starting this medication. It is essential to disclose any history of cancer, endocrine disorders, or autoimmune diseases to your healthcare provider, as these conditions may be significantly impacted by the components of porcine marrow.
No FDA black box warnings for Sus Scrofa Bone Marrow have been issued to date. However, users should be aware that biological products of animal origin carry unique risks, including the theoretical potential for zoonotic (animal-to-human) disease transmission, although modern pharmaceutical processing and sterilization techniques make this risk extremely low.
Individuals with a known allergy to pork, porcine-derived insulin, or other pig products must not use Sus Scrofa Bone Marrow. Allergic reactions can range from mild skin rashes to life-threatening anaphylaxis. Because this is a "Non-Standardized Animal Skin Allergenic Extract [EPC]" and "Non-Standardized Food Allergenic Extract [EPC]," the risk of cross-reactivity is high.
Because this extract is classified with Recombinant Human Growth Hormone and Lymphocyte Growth Factor, there is a theoretical risk that it could stimulate the growth of pre-existing, undiagnosed malignancies. It should be used with extreme caution in patients with a family history of hormone-dependent cancers.
To ensure the safe use of Sus Scrofa Bone Marrow, the following laboratory tests are typically required every 3 to 6 months:
Sus Scrofa Bone Marrow may cause dizziness, flushing, or sudden changes in blood pressure (due to its nitrate vasodilator properties). Patients should observe how they react to the medication before driving or operating heavy machinery. If you experience lightheadedness or blurred vision, avoid these activities and consult your doctor.
Alcohol consumption should be limited while taking Sus Scrofa Bone Marrow. Alcohol can exacerbate the vasodilatory effects of the nitrates in the marrow, leading to a dangerous drop in blood pressure. Furthermore, alcohol increases the strain on the liver, which is already processing the high vitamin and hormone content of the extract.
Do not stop taking Sus Scrofa Bone Marrow suddenly if you have been using it for an extended period. Because of its hormonal components, abrupt discontinuation can lead to a "rebound" effect or withdrawal-like symptoms, such as extreme fatigue, mood swings, or joint pain. Your healthcare provider will provide a tapering schedule to allow your endocrine system to resume its normal function gradually.
> Important: Discuss all your medical conditions, especially any history of cancer or hormone disorders, with your healthcare provider before starting Sus Scrofa Bone Marrow.
Certain medications must never be combined with Sus Scrofa Bone Marrow due to the risk of severe, life-threatening interactions:
Sus Scrofa Bone Marrow can interfere with several common laboratory tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the only way to prevent dangerous drug-drug interactions.
Sus Scrofa Bone Marrow must NEVER be used in patients with the following conditions:
Conditions requiring a careful risk-benefit analysis by a specialist include:
Patients who have experienced allergic reactions to the following may also be sensitive to Sus Scrofa Bone Marrow:
> Important: Your healthcare provider will evaluate your complete medical history and perform necessary allergy testing before prescribing Sus Scrofa Bone Marrow.
Sus Scrofa Bone Marrow is generally contraindicated during pregnancy. While it does not have a formal FDA pregnancy category (like A, B, C, D, X), its pharmacological profile suggests significant risk. The presence of androgen and estrogen receptor agonists can disrupt the delicate hormonal environment necessary for fetal development, potentially leading to virilization of a female fetus or other teratogenic effects. Furthermore, the high Vitamin A content (retinol) is a known teratogen when taken in excess, associated with craniofacial and cardiac malformations in the developing embryo. Pregnant women should avoid all forms of porcine bone marrow extract.
It is not known whether the specific hormonal agonists or growth factors in Sus Scrofa Bone Marrow pass into human breast milk. However, many small molecules and fat-soluble vitamins do. There is a theoretical risk that the nursing infant could be exposed to porcine-derived T3, growth hormones, or excess Vitamin D, which could interfere with the infant's own endocrine development. Because the safety has not been established, breastfeeding mothers are advised to discontinue the use of this extract or switch to infant formula.
As noted in the dosage section, Sus Scrofa Bone Marrow is not approved for general use in children. The inclusion of "Recombinant Human Growth Hormone [EPC]" and sex hormone agonists makes it particularly dangerous for those whose growth plates have not yet fused. Use in children is restricted to highly specialized cases of refractory anemia or immune deficiency, and only under the supervision of a pediatric sub-specialist. Monitoring for accelerated bone age and premature puberty is required.
Elderly patients are at an increased risk for adverse effects from Sus Scrofa Bone Marrow. Age-related declines in renal and hepatic function mean that vitamins and hormones may accumulate to toxic levels more quickly. Furthermore, the "Nitrate Vasodilator [EPC]" and "Antiarrhythmic [EPC]" properties pose a risk for seniors with underlying cardiovascular disease, potentially causing orthostatic hypotension (dizziness upon standing) and increasing the risk of falls and fractures.
For patients with moderate renal impairment (CrCl 30-60 mL/min), the dosage of Sus Scrofa Bone Marrow should be reduced by at least 30%. In severe impairment (CrCl < 30 mL/min), the risk of hyperphosphatemia and hypercalcemia is significant. These patients require frequent monitoring of serum electrolytes. Dialysis does not effectively clear the large protein-bound components of the marrow.
In patients with chronic liver disease, the synthesis of transport proteins (like albumin) is reduced, leading to higher levels of "free" (active) hormones and vitamins from the extract. This increases the risk of systemic toxicity. Sus Scrofa Bone Marrow should be avoided in patients with Child-Pugh Class C cirrhosis and used with extreme caution in Class B.
> Important: Special populations require individualized medical assessment. Never start this medication if you belong to one of these groups without a specialist's consultation.
Sus Scrofa Bone Marrow functions through a complex interplay of biological signals. Its Acidifying Activity [MoA] helps modulate the local pH of tissues, which can influence enzymatic reactions and the solubility of minerals. The Calcium Chelating Activity [MoA] involves the binding of divalent cations, which can alter the function of calcium-sensing receptors on cell surfaces.
At the endocrine level, the extract contains ligands that act as Estrogen Receptor Agonists and Androgen Receptor Agonists. These ligands enter the cell nucleus, bind to their respective receptors, and initiate the transcription of genes involved in cellular repair, protein synthesis, and metabolic regulation. The presence of l-Triiodothyronine (T3) directly stimulates the basal metabolic rate by increasing the activity of the Na+/K+ ATPase pump in nearly all tissues. Furthermore, the Lymphocyte Growth Factor and Interferon gamma components act on cell-surface receptors of the immune system to stimulate the JAK-STAT signaling pathway, enhancing the body's defensive capabilities.
The pharmacodynamic effects of Sus Scrofa Bone Marrow are characterized by a slow onset and a prolonged duration of action. While the vasodilatory effects of the nitrates may be felt within 30-60 minutes, the hormonal and immunological benefits typically require 2 to 4 weeks of consistent dosing to become apparent. This is because the primary effects rely on changes in gene expression and cellular maturation rather than immediate receptor blockade or activation.
| Parameter | Value |
|---|---|
| Bioavailability | Variable (30-60% for vitamins) |
| Protein Binding | High (>85% for hormonal components) |
| Half-life | 12 - 48 hours (composite) |
| Tmax | 2 - 4 hours (for small molecules) |
| Metabolism | Hepatic (CYP3A4, CYP1A2) |
| Excretion | Renal (60%), Fecal (40%) |
Sus Scrofa Bone Marrow is categorized as a Glandular Therapeutic Agent. Within the EPC system, it is primarily classified as Vitamin C [EPC], but it shares therapeutic space with Hormone Replacement Therapies, Biological Response Modifiers, and Nutritional Supplements. Its multi-class nature reflects the inherent complexity of whole-organ extracts compared to purified synthetic drugs.
Medications containing this ingredient
Common questions about Sus Scrofa Bone Marrow
Sus Scrofa Bone Marrow is primarily used in glandular therapy to support the body's hematopoietic (blood-forming) and immune systems. It is often prescribed by integrative practitioners for patients dealing with chronic fatigue, anemia, or immune deficiencies. Because it contains vitamins A, C, and D, as well as growth factors and hormonal precursors, it may also be used to support metabolic health and bone density. Some formulations utilize its calcium-chelating properties to assist in the dissolution of certain mineral deposits. However, its use should always be directed by a healthcare professional due to its complex biological activity.
The most frequently reported side effects include gastrointestinal issues such as nausea, bloating, and mild stomach discomfort, which often occur as the body adjusts to the rich protein and lipid content of the extract. Some patients may also experience mild headaches, flushing, or a temporary increase in appetite. Because the extract has hormonal properties, some users might notice mood shifts or changes in sleep patterns during the first few weeks of treatment. Most of these effects are mild and transient, but persistent symptoms should be reported to a doctor. It is important to monitor for any signs of an allergic reaction, especially if you have a history of sensitivity to pork products.
It is generally advised to avoid or significantly limit alcohol consumption while taking Sus Scrofa Bone Marrow. Alcohol can interact with the nitrate vasodilator components of the marrow, potentially causing a sudden and dangerous drop in blood pressure, leading to dizziness or fainting. Additionally, both alcohol and the high vitamin/hormone content of the marrow are processed by the liver, and combining them can increase the risk of hepatic strain or toxicity. Alcohol may also interfere with the absorption of the essential nutrients provided by the extract. Always consult your healthcare provider regarding your specific risk factors before consuming alcohol with this medication.
No, Sus Scrofa Bone Marrow is generally considered unsafe for use during pregnancy and should be avoided. The extract contains active estrogen and androgen receptor agonists that can interfere with the normal hormonal balance required for a healthy pregnancy and fetal development. Furthermore, the high concentration of Vitamin A (retinol) in bone marrow extracts is a known risk factor for birth defects when consumed in high amounts. There is also a lack of clinical data to guarantee its safety for the developing embryo. Pregnant women or those planning to become pregnant should discuss safer nutritional alternatives with their obstetrician.
The time it takes to see results from Sus Scrofa Bone Marrow can vary depending on the condition being treated, but it is generally not an immediate-acting medication. While some minor effects on energy levels or vasodilation might be noticed within a few days, the primary therapeutic benefits—such as improved immune function or hormonal balance—typically take 2 to 4 weeks of consistent use to manifest. This is because the extract works by modulating gene expression and supporting cellular maturation, which are gradual biological processes. Patients are usually advised to complete a full course of treatment as prescribed before evaluating its effectiveness. Your doctor will likely perform follow-up blood tests to monitor your progress.
You should not stop taking Sus Scrofa Bone Marrow abruptly without first consulting your healthcare provider, especially if you have been taking it for a long period. Because the extract contains hormonal precursors and T3, your body's endocrine system may have adjusted its own hormone production in response to the supplement. Stopping suddenly can cause a temporary hormonal imbalance, leading to symptoms like extreme fatigue, joint pain, or mood swings. A gradual tapering of the dose is usually recommended to allow your body to resume its natural hormone production safely. Always follow the specific discontinuation plan provided by your medical professional.
If you miss a dose of Sus Scrofa Bone Marrow, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for the missed one, as this can increase the risk of side effects like nausea or hormonal spikes. Consistency is key for glandular therapy, so try to take your medication at the same time each day. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm.
Weight gain is a possible, though not universal, side effect of Sus Scrofa Bone Marrow. This can occur due to several factors, including the androgenic and growth hormone-like effects of the extract, which can increase muscle mass or stimulate appetite. Some patients may also experience mild fluid retention, which can show up as an increase on the scale. However, the l-Triiodothyronine (T3) component of the marrow can also increase metabolic rate, which might offset weight gain in some individuals. If you notice significant or rapid changes in your weight, you should discuss them with your doctor to determine the underlying cause.
Sus Scrofa Bone Marrow has a high potential for drug interactions due to its complex biological makeup. It should not be taken with blood thinners like Warfarin, erectile dysfunction drugs like Sildenafil, or other hormone-based therapies without strict medical supervision. The vitamins and minerals in the marrow can also affect how other drugs are absorbed or metabolized by the liver. It is critical to provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medications, and herbal supplements you are currently taking. Your doctor will help you manage these interactions to ensure your treatment is both safe and effective.
Sus Scrofa Bone Marrow is a biological extract rather than a synthetic chemical drug, so the concept of a 'generic' version is slightly different than with standard pharmaceuticals. It is available under various brand names and as a non-branded bulk extract from different manufacturers. However, because these are biological products, the concentration of active components like hormones and growth factors can vary significantly between different brands. It is important to use a high-quality, standardized source and to stay with the same brand throughout your treatment if possible. Your pharmacist or doctor can recommend a reputable manufacturer that meets current Good Manufacturing Practices (cGMP).